Covance Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10,718


  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 6

  • Investments
  • 19

Covance General Information


Provider of contract research services intended to serve drug, medical device and diagnostics, crop protection and chemical industries. The company offers drug development, nonclinical safety assessment, bioanalytical service, clinical trial testing, toxicology, clinical trial management and other consulting services, providing end-to-end drug development support to a wide range of industries.

Contact Information

Formerly Known As
Corning Pharmaceutical Services, Corning Pharmaceutical Services Inc
Ownership Status
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Parent Company
Nao Medical
Corporate Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States
+1 (609) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covance Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covance‘s full profile, request access.

Request a free trial

Covance Comparisons

HQ Location
Total Raised
Post Valuation
Provider of contract research services intended to serve drug, medical device and diagnostics, crop protection and chemi
Drug Discovery
Princeton, NJ
10,718 As of 2023
000000000 00


mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
0000 000000000
Durham, NC
00000 As of 0000
000000000 00 00000


voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000000000 00000000
Wilmington, NC
00000 As of 0000
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Covance Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Parexel International Private Equity-Backed Durham, NC 00000 00000 000000000 00 00000
Pharmaceutical Product Development Formerly PE-Backed Wilmington, NC 00000 000.00 000000&0 000.00
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom 0000 000000000 -
Charles River Laboratories International Formerly PE-Backed Wilmington, MA 00000 00.000 000000000 - 00.000
Aragen Life Sciences Private Equity-Backed Hyderabad, India 0000 0000 00000000000 0000
You’re viewing 5 of 24 competitors. Get the full list »

Covance Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Covance Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covance‘s full profile, request access.

Request a free trial

Covance Investments & Acquisitions (19)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biomakers 15-Mar-2023 00000 0000 0000 Discovery Tools (Healthcare)
snapIoT 02-Oct-2020 0000000000 Enterprise Systems (Healthcare)
GlobalCare Clinical Trials 01-Jul-2020 0000000000 Clinics/Outpatient Services
RCRI 09-Apr-2019 0000000000 Consulting Services (B2B)
MI Bioresearch 07-Mar-2019 Merger/Acquisition Laboratory Services (Healthcare)
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

Covance Subsidiaries (1)

Company Name Industry Location Founded
Covance Laboratories Pension Scheme Corporate Pension Harrogate, United Kingdom 0000
To view Covance’s complete subsidiaries history, request access »

Covance ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies







Medical Services




To view Covance’s complete esg history, request access »

Covance FAQs

  • When was Covance founded?

    Covance was founded in 1996.

  • Who is the founder of Covance?

    John Scarlett MD is the founder of Covance.

  • Where is Covance headquartered?

    Covance is headquartered in Princeton, NJ.

  • What is the size of Covance?

    Covance has 10,718 total employees.

  • What industry is Covance in?

    Covance’s primary industry is Drug Discovery.

  • Is Covance a private or public company?

    Covance is a Private company.

  • What is Covance’s current revenue?

    The current revenue for Covance is 00000.

  • How much funding has Covance raised over time?

    Covance has raised $125M.

  • Who are Covance’s investors?

    Corning, Health Cloud Capital, and Laboratory Corporation of America have invested in Covance.

  • Who are Covance’s competitors?

    Parexel International, Pharmaceutical Product Development, Sygnature Discovery, Charles River Laboratories International, and Aragen Life Sciences are some of the 24 competitors of Covance.

  • When was Covance acquired?

    Covance was acquired on 01-Jul-2001.

  • Who acquired Covance?

    Covance was acquired by Nao Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »